See more : PT Jaya Real Property, Tbk. (JRPT.JK) Income Statement Analysis – Financial Results
Complete financial analysis of Ginkgo Bioworks Holdings, Inc. WT (DNA-WT) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Ginkgo Bioworks Holdings, Inc. WT, a leading company in the Biotechnology industry within the Healthcare sector.
You may be interested
- Cityman Limited (CITYMAN.BO) Income Statement Analysis – Financial Results
- Spire Inc. (SRCU) Income Statement Analysis – Financial Results
- Assurant, Inc. 5.25% Subordinat (AIZN) Income Statement Analysis – Financial Results
- Aditya Birla Fashion and Retail Limited (ABFRL.BO) Income Statement Analysis – Financial Results
- The Miyazaki Bank, Ltd. (8393.T) Income Statement Analysis – Financial Results
Ginkgo Bioworks Holdings, Inc. WT (DNA-WT)
Industry: Biotechnology
Sector: Healthcare
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2001 |
|---|---|---|---|---|---|---|
| Revenue | 251.46M | 477.71M | 313.84M | 76.66M | 54.18M | 98.29M |
| Cost of Revenue | 54.01M | 204.22M | 129.69M | 15.61M | 0.00 | 0.00 |
| Gross Profit | 197.45M | 273.49M | 184.15M | 61.05M | 54.18M | 98.29M |
| Gross Profit Ratio | 78.52% | 57.25% | 58.68% | 79.64% | 100.00% | 100.00% |
| Research & Development | 580.62M | 1.05B | 1.15B | 159.77M | 96.30M | 100.48M |
| General & Administrative | 385.03M | 1.43B | 862.95M | 38.31M | 29.48M | 77.39M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 385.03M | 1.43B | 862.95M | 38.31M | 29.48M | 77.39M |
| Other Expenses | 96.21M | 7.63M | -1.73M | 16.13M | 1.57M | 0.00 |
| Operating Expenses | 1.06B | 2.48B | 2.01B | 198.07M | 125.78M | 177.87M |
| Cost & Expenses | 1.12B | 2.69B | 2.14B | 213.68M | 125.78M | 177.87M |
| Interest Income | 57.22M | 20.26M | 837.00K | 2.58M | 5.76M | 0.00 |
| Interest Expense | 93.00K | 106.00K | 2.37M | 2.39M | 2.42M | 0.00 |
| Depreciation & Amortization | 71.55M | 61.63M | 29.08M | 13.86M | 10.76M | 14.80M |
| EBITDA | -821.29M | -2.06B | -1.81B | -108.59M | -106.66M | -219.71M |
| EBITDA Ratio | -326.62% | -456.43% | -598.26% | -140.25% | -149.58% | -223.55% |
| Operating Income | -864.41M | -2.21B | -1.83B | -137.03M | -71.60M | -234.51M |
| Operating Income Ratio | -343.76% | -462.41% | -582.62% | -178.75% | -132.14% | -238.60% |
| Total Other Income/Expenses | -28.53M | 87.55M | -9.66M | 12.19M | -48.24M | 0.00 |
| Income Before Tax | -892.94M | -2.12B | -1.84B | -124.83M | -119.84M | 0.00 |
| Income Before Tax Ratio | -355.11% | -444.08% | -585.69% | -162.85% | -221.16% | 0.00% |
| Income Tax Expense | -71.00K | -15.03M | -1.48M | 1.89M | 22.00K | 0.00 |
| Net Income | -892.87M | -2.10B | -1.83B | -126.61M | -119.33M | 0.00 |
| Net Income Ratio | -355.08% | -440.63% | -583.12% | -165.16% | -220.23% | 0.00% |
| EPS | -18.37 | -50.15 | -53.83 | -0.09 | -0.08 | 0.00 |
| EPS Diluted | -18.37 | -50.12 | -53.81 | -0.09 | -0.08 | 0.00 |
| Weighted Avg Shares Out | 48.61M | 41.98M | 34.00M | 1.49B | 1.49B | 0.00 |
| Weighted Avg Shares Out (Dil) | 48.61M | 42.00M | 34.01M | 1.49B | 1.49B | 0.00 |
No news found for: DNA-WT
Source: https://incomestatements.info
Category: Stock Reports